Bremelanotide (Vyleesi)

Melanocortin receptor agonist

  • Sexual dysfunction Female
  • Can cause permanent skin discoloration

Features

, , , , , , , ,
Handout

Dosing

Bremelanotide 1.75mg/0.3mL, 0.3mL SC inj 45 minutes before sexual activity (max 8 per month)

Management

A hormonal injection that is FDA approved but not very desirable because it can cause discoloration of skin at injection site.

EMR Text

Diagnosis1

StartText1

WarningText1

Diagnosis2

StartText2

WarningText2

Search Treatments
Scroll to Top